The incidence and significance of atrial dysrhythmias in rheumatic valvular disease.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001022:Aortic Valve Insufficiency / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D001024:Aortic Valve Stenosis / Q000209:etiology / Q000503:physiopathology; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D001282:Atrial Flutter / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D005117:Cardiac Complexes, Premature; D004554:Electric Countershock; D006329:Heart Conduction System / Q000503:physiopathology; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D008946:Mitral Valve Stenosis / Q000150:complications / Q000503:physiopathology; D012214:Rheumatic Heart Disease / Q000150:complications*
D000319:Adrenergic beta-Antagonists